The announcement came without ceremony but carried real consequences. The Department of Health and Human Services reduced the number of vaccines recommended on the routine pediatric schedule from seventeen to eleven, shifting several shots from automatic inclusion to shared decision-making between parents and physicians. No vaccines were banned. None was forbidden. Yet the response from institutional medicine was immediate and hostile, as if the mere suggestion of choice threatened public order.
Clayton Baker learned of the decision only hours before speaking about it, and he grasped instantly why the reaction would be so fierce. “Shared decision-making is being treated like a scandal when it is just informed consent by another name.” The outrage, in his view, revealed how far modern medicine has drifted from its own ethical foundations.
The policy change did not emerge in isolation. The administration explicitly pointed to other advanced nations, including Denmark and Japan, that operate with far leaner pediatric schedules. Japan, with more than 120 million people, delays most childhood vaccines until after the second birthday and has seen improved health outcomes as a result. Yet critics dismissed such comparisons as irrelevant, arguing that the United States is uniquely fragile, uniquely diverse, and uniquely incapable of tolerating a similar approach.
Baker found that argument unserious. “We are still human beings,” he said flatly. He contrasted the panic of the present with the lived experience of earlier generations. He grew up in a time when children routinely encountered measles and chickenpox, often deliberately, and emerged with lasting immunity. “We lived through measles and chickenpox without thinking the world was ending,” he noted. The claim that any reduction in pharmaceutical intervention invites disaster struck him as ideological rather than medical.
The revised schedule retains long-established vaccines such as DPT, polio, MMR, pneumococcus, varicella, and HPV, though HPV is now recommended as a single dose rather than two. Removed from universal recommendation are hepatitis A and B, meningitis, dengue, RSV, influenza, and COVID-19, which now fall under risk-based or shared clinical decision frameworks. For Baker, the most consequential aspect of this change is not symbolic but biological. “Reducing antigenic burden in infants is not radical. It is common sense.”
Under the previous schedule, infants often received six or more injections in a single visit. Baker emphasized that this level of immune stimulation was historically unprecedented and disproportionately affected vulnerable populations. The new framework sharply reduces that load, particularly by removing routine mRNA-based shots from early childhood.
That point, for Baker, is central. “A baby does not need an mRNA injection on day one of life,” he said. He does not view mRNA as inherently useless, but he rejects its deployment as a mass, repetitive platform for respiratory viruses in low-risk populations. “The mRNA platform was never tested for this kind of mass, repeated use,” he argued, and its rapid normalization bypassed the safeguards that once defined pharmaceutical development.
His concern has only deepened as new data has emerged. Large observational studies from South Korea and Italy compared cancer incidence in vaccinated versus unvaccinated populations during the year following COVID mRNA injections. Both showed a statistically significant increase in overall cancer diagnoses among the vaccinated, with striking overlap in specific cancers such as lung and prostate. Baker does not claim definitive causation, but he refuses dismissal. “When you see the same signal in different countries, you have an obligation to investigate, not to shut people up.”
Yet suppression, he argued, has become the default response. He cited the recent cyberattack that disabled a medical journal preparing to publish a comprehensive review of mRNA-related cancer literature. “When journals are hacked instead of debated,” Baker said, “you know the science is in trouble.” The attack did not refute the findings. It erased the forum.
That pattern extends beyond vaccines to the pharmaceutical industry itself. Baker pointed to repeated criminal penalties, regulatory capture, and media conflicts of interest as evidence of systemic corruption. He is particularly critical of semantic maneuvering that reclassifies gene therapies as vaccines in order to secure liability protection. “If everything is called a vaccine,” he said, “you cannot sue when it kills you.”
The HPV vaccine, in his view, illustrates the broader moral hazard. Promoted as harm reduction, it presumes inevitable adolescent sexual behavior and substitutes pharmaceutical intervention for restraint, screening, and informed consent. “Harm reduction sounds compassionate,” Bock said, “but it often smuggles in moral surrender.” Given documented autoimmune risks and the availability of routine Pap screening, he questioned whether the risk-benefit calculus ever justified mass administration to young girls.
Beneath all of this lies a larger diagnosis. Modern medicine has pathologized ordinary life. Anxiety, attention, addiction, and development have been medicalized, insured, and monetized, creating permanent patients rather than resilient adults. Vaccination policy, Baker argued, has followed the same trajectory. Every deviation from statistical perfection becomes a condition demanding intervention.
What troubles him most is not disagreement but absolutism. “Trust does not survive systematic lying,” he said. The ferocity of the response to a modest schedule reduction revealed how little dissent the system can tolerate. No concession is allowed. No recalibration is permitted. Either the entire apparatus is correct, or catastrophe looms.
For Baker, that rigidity is the warning sign. Medicine once advanced through humility, debate, and revision. When it demands obedience without transparency, it forfeits the authority it seeks to preserve.
Transcript Summary of this podcast episode ⤵Full Transcript (Auto-Transcribed)
When HHS trimmed the pediatric vaccine schedule from 17 antigens to 11, it should have been a quiet return to a simple principle. Medicine must begin with informed consent and the right of parents to decide for their children. That is not a concession to fear. It is basic respect for bodily autonomy.
The move acknowledges something many clinicians have been saying all along. Not every shot belongs on a universal childhood timetable. Some belong to targeted risk groups. Some require a conversation. Shared decision making must be more than a slogan. It must replace the automatic, one-size-fits-all posture that treats children as assembly-line patients.
We also must face the uncomfortable facts about the mRNA platform. It was rushed into billions of arms with minimal phase three safety data. Large observational signals have been reported that deserve rigorous study. When novel biology is pushed at scale, the right response is caution, transparency, and independent follow-up. We do not get to declare experiments finished because industry says so.
HPV shots are a case study in harm reduction masquerading as prevention. Harm reduction makes sense when no other option exists. Mass vaccinating children for a sexually transmitted virus because adults will not change behavior is a policy choice, not a medical necessity. It deserves honest debate without moral panic.
Finally, none of this can be divorced from the reality of power and profit. Major drug makers have paid billions in penalties and have too often traded credibility for market share. When regulators, industry, and academic medicine move as one, trust evaporates. Restoring it means putting patients first, demanding full data access, and insisting that every medical intervention be justified, proportional, and reversible.
Medicine is a covenant, not a contract. If we want healthy communities, start by honoring individual liberty, by respecting informed consent, and by insisting that new technologies prove their safety before we give them to our children.
Join us at 5 pm ET weekdays on America Out Loud Talk Radio. Listen on iHeart Radio, our world-class media player, or our free apps on Apple, Android, or Alexa. Discover all the episodes on podcast networks, i.e., Apple Podcasts, Spotify, Pandora, TuneIn, Stitcher, and iHeart. You’ll find them the day after they air on talk radio, available on podcast. Extraordinary voices for extraordinary times.
Discover more from Randy Bock MD PC
Subscribe to get the latest posts sent to your email.
